View on Pubmed.gov 30883058 | View on doi.org 10.1056/NEJMoa1...
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
- From Baylor Scott and White Health, Plano, TX (M.J.M., D.L.B.); Columbia University Irving Medical Center and New York-Presbyterian Hospital (M.B.L., S.K.K., R.T.H., M.C.A., C.R.S.) and New York University Langone Medical Center (M.R.W.) - both in New York; Medstar Heart and Vascular Institute, Georgetown University, Washington, DC (V.H.T.); Cedars-Sinai Heart Institute, Los Angeles (R.M.); Robert Wood Johnson Medical School, Rutgers University, New Brunswick (M.R.), and Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown (P.G.) - both in New Jersey; Cleveland Clinic, Cleveland (S.R.K.); Feinberg School of Medicine, Northwestern University, Chicago (S.C.M.); Saint Luke's Mid America Heart Institute, Kansas City, MO (D.J.C.); Quebec Heart and Lung Institute, Laval University, Quebec, QC (P.P.), and St. Paul's Hospital, University of British Columbia, Vancouver (J.L., P.B., J.G.W.) - both in Canada; University of Washington, Seattle (J.M.M.); Emory University Hospital, Atlanta (V.B.); Lankenau Medical Center, Wynnewood (S.G.), and the Hospital of the University of Pennsylvania, Philadelphia (W.Y.S.) - both in Pennsylvania; Banner University Medical Center, Phoenix, AZ (A.P.); and the London School of Hygiene and Tropical Medicine, London (S.J.P.).
PARTNER 3 Investigators
- Mohammad El-Hajjar,
- Stephen Bailey,
- John Brown,
- Robert Kipperman,
- Mark Webster,
- Frank Zidar,
- Faraz Kerendi,
- Ashish Pershad,
- Kenith Fang,
- H Garrett,
- Basil Paulus,
- Pinak Shah,
- Tsuyoshi Kaneko,
- Bassem Chehab,
- Brett Grizzell,
- Michael Rinaldi,
- Eric Skipper,
- Raj Makkar,
- Alfredo Trento,
- Andrew Eisenhauer,
- Susheel Kodali,
- Isaac George,
- Tamim Nazif,
- Shing Chiu Wong,
- Arash Salemi,
- James DeVries,
- Joseph DeSimone,
- Vinod Thourani,
- Robert Guyton,
- Vasilis Babaliaros,
- Kevin Accola,
- Raymond McKay,
- Robert Hagberg,
- William O'Neill,
- Gaetano Paone,
- DImitrios Apostolou,
- Jorge Castellanos,
- Anthony Caffarelli,
- Shahram Yazdani,
- Eric Sarin,
- Brian Whisenant,
- Kent Jones,
- Marcos Nores,
- Mark Rothenberg,
- Edward McNulty,
- Richard Richter,
- Kentaro Hayashida,
- Paul Coady,
- Scott Goldman,
- David Holmes,
- Kevin Greason,
- Bruce Bowers,
- Todd Dewey,
- David Daniels,
- Conrad Vial,
- Noah Jones,
- Patrick Wells,
- Steve Xydas,
- Nirat Beohar,
- Willis Wu,
- Curtis Anderson,
- Steven Martin,
- James Wudel,
- Mathew Williams,
- Mark Russo,
- Bruce Haik,
- Ted Feldman,
- Hyde Russell,
- Chris Malaisrie,
- Charles Davidson,
- Stephen Ramee,
- Patrick Parrino,
- Mark Bodenhamer,
- Mohammad Ghani,
- Yasushi Sakata,
- John Gill,
- Robert Hodson,
- Jeffrey Swanson,
- Joseph Montarello,
- Clifford Kavinsky,
- Adnan Chhatriwalla,
- Evelio Rodriguez,
- Andrew Morse,
- Paul Mahoney,
- Joseph Newton,
- John Webb,
- Craig Miller,
- Alan Yeung,
- Pei-Hsiu Huang,
- Michael Ingram,
- Ken Kozuma,
- Dean Kereiakes,
- Geoffrey Answini,
- Samir Kapadia,
- David Brown,
- Michael Mack,
- Christian Spies,
- Benjamin Plank,
- Jeffrey Lau,
- Richard Smalling,
- Tuyen Tom Nguyen,
- Brad Oldemeyer,
- Mark Guadagnoli,
- Vijay Iyer,
- Gary Grosner,
- James Davies,
- Richard Shemin,
- William Suh,
- Thomas Beaver,
- David Anderson,
- Phillip Horwitz,
- Gregory Helmer,
- Kenneth Liao,
- Joseph Bavaria,
- Howard Herrmann,
- Gorav Ailawadi,
- James McCabe,
- Gabriel Aldea,
- Giorgio Gimelli,
- Lucian Lozonschi,
- Satoru Osaki,
- Alan Zajarias,
- Hersh Maniar,
- George Hanzel,
- Francis Shannon,
- Richard Schwartz,
- William Nicholson,
- Mark Burlingame.
Abstract
BACKGROUND
Among patients with aortic stenosis who are at intermediate or high risk for death with surgery, major outcomes are similar with transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement. There is insufficient evidence regarding the comparison of the two procedures in patients who are at low risk.
METHODS
We randomly assigned patients with severe aortic stenosis and low surgical risk to undergo either TAVR with transfemoral placement of a balloon-expandable valve or surgery. The primary end point was a composite of death, stroke, or rehospitalization at 1 year. Both noninferiority testing (with a prespecified margin of 6 percentage points) and superiority testing were performed in the as-treated population.
RESULTS
At 71 centers, 1000 patients underwent randomization. The mean age of the patients was 73 years, and the mean Society of Thoracic Surgeons risk score was 1.9% (with scores ranging from 0 to 100% and higher scores indicating a greater risk of death within 30 days after the procedure). The Kaplan-Meier estimate of the rate of the primary composite end point at 1 year was significantly lower in the TAVR group than in the surgery group (8.5% vs. 15.1%; absolute difference, -6.6 percentage points; 95% confidence interval [CI], -10.8 to -2.5; P<0.001 for noninferiority; hazard ratio, 0.54; 95% CI, 0.37 to 0.79; P = 0.001 for superiority). At 30 days, TAVR resulted in a lower rate of stroke than surgery (P = 0.02) and in lower rates of death or stroke (P = 0.01) and new-onset atrial fibrillation (P<0.001). TAVR also resulted in a shorter index hospitalization than surgery (P<0.001) and in a lower risk of a poor treatment outcome (death or a low Kansas City Cardiomyopathy Questionnaire score) at 30 days (P<0.001). There were no significant between-group differences in major vascular complications, new permanent pacemaker insertions, or moderate or severe paravalvular regurgitation.
CONCLUSIONS
Among patients with severe aortic stenosis who were at low surgical risk, the rate of the composite of death, stroke, or rehospitalization at 1 year was significantly lower with TAVR than with surgery. (Funded by Edwards Lifesciences; PARTNER 3 ClinicalTrials.gov number, NCT02675114.).
References
Cited by 4104 citations (total)
Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.
Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
Electronic publication date September 29, 2020
Amgad Mentias [...] Mary Vaughan Sarrazin et al.
OBJECTIVES
This study sought to evaluate impact of new-onset and pre-existing atrial fibrillation (AF) on transcatheter aortic valve replacement (TAVR) long-term...
Journal Article
Assessment of Kidney Function After Transcatheter Aortic Valve Replacement.
Electronic publication date June 24, 2021
Orit Kliuk-Ben Bassat [...] Yaron Arbel et al.
BACKGROUND
Transcatheter aortic valve replacement (TAVR), although associated with an increased risk for acute kidney injury (AKI), may also result in...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
Copyright
Copyright © 2019 Massachusetts Medical Society.